Publications | Southampton Clinical Trials Unit

You can browse a selection of publications below or browse all publications in our ePrints repository.

Sort via:TypeorYear

Articles

Hunter, M. S., Nuttall, J., & Fenlon, D. (2019). A comparison of three outcome measures of the impact of vasomotor symptoms on women’s lives. Climacteric, 22(4), 419-423. DOI: 10.1080/13697137.2019.1580258
Hay, A. D., Downing, H., Francis, N. A., Young, G. J., Clement, C., Harris, S. D., ... Moore, M. V. (2019). Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT. Health technology assessment (Winchester, England), 23(34), 1-48. DOI: 10.3310/hta23340
Griffiths, G. O., Cowan, R. A., Grigor, K. M., Uscinska, B. M., Sydes, M., & Russell, M. (2019). BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract. PLoS ONE, 14(1), [e0210785]. DOI: 10.1371/journal.pone.0210785
Davies, A., Cummin, T., Barrans, S., Maishman, T., Mamot, C., Novak, U., ... Johnson, P. (2019). Gene expression profiling in an open-label randomised phase 3 trial (REMoDL-B) of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma. The Lancet Oncology, 20(5), 649-662. DOI: 10.1016/S1470-2045(18)30935-5
NBCS Collaborators (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120(6), 647-657. DOI: 10.1038/s41416-019-0393-x
Mavaddat, N., Durcan, L., Michailidou, K., & et al. (2019). Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. The American Journal of Human Genetics, 104(1), 21-34. DOI: 10.1016/j.ajhg.2018.11.002
Gandhi, A., Copson, E., Eccles, D., Durcan, L., Howell, A., Morris, J., ... Harvie, M. (2019). Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapy. The Breast, 1-6. DOI: 10.1016/j.breast.2019.02.006
Moore, M., Trill, J., Simpson, C., Webley, F., Radford, M., Stanton, L., ... Griffiths, G. (2019). Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. Clinical Microbiology and Infection, 1-8. DOI: 10.1016/j.cmi.2019.01.011
Gollins, S., West, N., Sebag-Montefiore, D., Susnerwala, S., Falk, S., Brown, N., ... Hurt, C. (2018). A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer, 1-10. DOI: 10.1038/s41416-018-0209-4
Hall, C. C., Norris, L., Cook, J., Maddocks, M., Graham, C., Tuck, S., ... Dixon, E. (2018). A randomised, phase II, unblinded trial of an Exercise and Nutrition-based Rehabilitation programme (ENeRgy) versus standard care in patients with cancer: feasibility trial protocol. Pilot and Feasibility Studies, 4, [192]. DOI: 10.1186/s40814-018-0381-6
Lester, J., Casbard, A., Al-Taei, S., Harrop, R., Katona, L., Attanoos, R. L., ... Griffiths, G. (2018). A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma – the SKOPOS trial. OncoImmunology, 7(12), 1-11. [e1457597]. DOI: 10.1080/2162402X.2018.1457597
Wu, L., Shi, W., Long, J., Guo, X., Michailidou, K., Beesley, J., ... NBCS Collaborators (2018). A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics, 50(7), 968-978. DOI: 10.1038/s41588-018-0132-x
Papadakis, E. S., Reeves, T., Robson, N. H., Maishman, T., Packham, G., & Cutress, R. (2018). BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses. British Journal of Cancer, 118, 1152–1153. DOI: 10.1038/s41416-018-0023-z
Solheim, T. S., Laird, B. J. A., Balstad, T. R., Bye, A., Stene, G., Baracos, V., ... Fearon, K. (2018). Cancer cachexia: Rationale for the MENAC (Multimodal - Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Supportive & Palliative Care. DOI: 10.1136/bmjspcare-2017-001440
Fennell, D. A., Kirkpatrick, E., Cozens, K., Nye, M., Lester, J., Hanna, G., ... Griffiths, G. (2018). CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial. Trials, 19(233), 1-10. DOI: 10.1186/s13063-018-2602-y
Hutchings, N., Wood, W., Reading, I., Walker, E., Blazeby, J. M., van't Hoff, W., ... Hall, N. J. (2018). CONTRACT Study - CONservative TReatment of Appendicitis in Children (feasibility): Study protocol for a randomised controlled Trial. Trials, 19(1), 1-10. [153]. DOI: 10.1186/s13063-018-2520-z, 10.1186/s13063-018-2520-z
Cook, J., Julious, S., Sones, W., Hampson, L., Hewitt, C., Berlin, J., ... Vale, L. (2018). DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. Trials, 19, [606]. DOI: 10.1186/s13063-018-2884-0
Cook, J. A., Julious, S. A., Sones, W., Hampson, L. V., Hewitt, C., Berlin, J. A., ... Vale, L. D. (2018). DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. BMJ, [363]. DOI: 10.1136/bmj.k3750
Bidmon, N., Kind, S., Welters, M. J. P., Joseph-Pietras, D., Laske, K., Maurer, D., ... van der Burg, S. H. (2018). Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance. Journal of Immunological Methods, 458, 74-82. DOI: 10.1016/j.jim.2018.04.007
Turner, S., Bull, A., Chinnery, F., Hinks, J., McArdle, N., Moran, R., ... Wyatt, J. C. (2018). Evaluation of stakeholder views on peer review of NIHR applications for funding: A qualitative study. BMJ Open, 8(12), [e022548]. DOI: 10.1136/bmjopen-2018-022548
Copson, E. R., Maishman, T. C., Tapper, W. J., Cutress, R. I., Greville-Heygate, S., Altman, D. G., ... Eccles, D. (2018). Germline BRCA mutation and outcome in young-onset breast cancer: POSH, a prospective cohort study. The Lancet Oncology, 19(2), 169-180. DOI: 10.1016/S1470-2045(17)30891-4
Fenlon, D., Nuttall, J., May, C., Raftery, J., Fields, J., Kirkpatrick, E., ... Hunter, M. (2018). MENOS4 trial: a multicentre randomised controlled trial (RCT) of a breast care nurse delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flushes in women with breast cancer: Study Protocol. BMC Women’s Health, 18(1), 1-10. DOI: 10.1186/s12905-018-0550-z
Ceriani, L., Milan, L., Martelli, M., Ferreri, A. J. M., Cascione, L., Zinzani, P. L., ... Zucca, E. (2018). Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. Blood, 132(2), 179-186. DOI: 10.1182/blood-2018-01-826958
Sha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., ... Westhead, D. . R. (2018). Molecular high-grade B-Cell lymphoma: defining a poor-risk group that requires different approaches to therapy. Journal of Clinical Oncology, 37(3), 202-213. [37]. DOI: 10.1200/JCO.18.01314
Cucco, F., Clipson, A., Kennedy, H., Sneath Thompson, J., Wang, M., Barrans, S., ... Du, M. Q. (2018). Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality. Laboratory Investigation, 1-9. DOI: 10.1038/s41374-018-0066-z
Prout, H. C., Barham, A., Bongard, E., Tudor-Edwards, R., Griffiths, G., Hamilton, W., ... Nelson, A. (2018). Patient understanding and acceptability of an early lung cancer diagnosis trial: A qualitative study. Trials, 19(1), [419]. DOI: 10.1186/s13063-018-2803-4
Bruton, A., Lee, A., Yardley, L., Raftery, J., Arden-Close, E., Kirby, S., ... Thomas, M. (2018). Physiotherapy breathing retraining for asthma: a randomised controlled trial. The Lancet Respiratory Medicine, 6(1), 19-28. DOI: 10.1016/S2213-2600(17)30474-5
Chorozoglou, M., Reading, I., Eaton, S., Hutchings, N., & Hall, N. J. (Accepted/In press). Protocol of health economics and quality of life in a feasibility RCT of paediatric acute appendicitis. BMJ Paediatrics Open.
Lim, S. H., Linton, K. M., Collins, G. P., Dhondt, J., Caddy, J., Rossiter, L., ... Griffiths, G. (2018). RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial. Trials, 19(1), [619]. DOI: 10.1186/s13063-018-2996-6
Blatch-Jones, A., Ashton-Key, M., Kirkpatrick, E. V., & Pek, W. (2018). Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study. BMJ Open, 8(9), 1-9. [e022233]. DOI: 10.1136/bmjopen-2018-022233
McKenzie, H. S., Mead, G., Huddart, R., White, J. D., Rustin, G. J. S., Hennig, I. M., ... Wheater, M. J. (2018). Salvage chemotherapy with gemcitabine, paclitaxel, ifosfamide, and cisplatin for relapsed germ cell cancer. Clinical Genitourinary Cancer. DOI: 10.1016/j.clgc.2018.07.006
Crabb, S., Danson, S. J., Catto, J. W. F., McDowell, C., Lowder, J. N., Caddy, J., ... Kalevras, M. (2018). SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials, 19(1), 216. DOI: 10.1186/s13063-018-2586-7
Cutress, R., Copson, E., Shaaban, A. M., Maishman, T., Moseley, P. M., Mckenzie, H., ... Berditchevski, F. (2018). The presentation, management and outcome of inflammatory breast cancer cases in the UK: data from a multi-centre retrospective review. The Breast, 42, 133-141. DOI: 10.1016/j.breast.2018.09.003
Sonuga-Barke, E. J. S., Barton, J., Daley, D., Hutchings, J., Maishman, T., Raftery, J., ... Thompson, M. J. J. (2017). A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years. European Child & Adolescent Psychiatry. DOI: 10.1007/s00787-017-1054-3
Candido do Reis, F. J., Wishart, G. C., Dicks, E. M., Greenberg, D., Rashbass, J., Schmidt, M. K., ... Pharoah, P. D. P. (2017). An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Research, 19(58). DOI: 10.1186/s13058-017-0852-3
Pugh, S., Thiebaut, R., Bridgewater, J., Grisoni, M-L., Moutasim, K., Rousseau, F., ... Laurent-Puig, P. (2017). Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial. Oncotarget. DOI: 10.18632/oncotarget.21291
Crabb, S. J., Martin, K., Abab, J., Ratcliffe, I., Thornton, R., Lineton, B., ... King, E. (2017). COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. European Journal of Cancer, 87, 75-83. DOI: 10.1016/j.ejca.2017.09.033
Hind, D., Reeves, B. C., Bathers, S., Bray, C., Corkhill, A., Hayward, C., ... Bradburn, M. (2017). Comparative costs and activity from a sample of UK clinical trials units. Trials, 18(1), [203]. DOI: 10.1186/s13063-017-1934-3
Reynolds, J. V., Preston, S. R., O’neill, B., Baeksgaard, L., Griffin, S. M., Mariette, C., ... Mc Dermott, R. (2017). ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS). BMC cancer, 17(1). DOI: 10.1186/s12885-017-3386-2
Milne, R. L., Kuchenbaeker, K. B., Michailidou, K., Eccles, D., Durcan, L., & Maishman, T. (2017). Identification of ten variants associated with risk of estrogen receptor negative breast cancer. Nature Genetics, 1-15. DOI: 10.17863/CAM.8923
Neal, R. D., Barham, A., Bongard, E., Edwards, R. T., Fitzgibbon, J., Griffiths, G., ... Hurt, C. N. (2017). Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer, 116(3), 293-302. DOI: 10.1038/bjc.2016.414
Cook, A., Streit, E., & Davage, G. (2017). Involving clinical experts in prioritising topics for health technology assessment: a randomised controlled trial. BMJ Open, 7, [e016104]. DOI: 10.1136/bmjopen-2017-016104
Hurt, C. N., Falk, S., Crosby, T., McDonald, A., Ray, R., Joseph, G., ... Mukherjee, S. (2017). Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. British Journal of Cancer, 116, 1264-1270. DOI: 10.1038/bjc.2017.95
Mukherjee, S., Hurt, C. N., Gwynne, S., Sebag-Montefiore, D., Radhakrishna, G., Gollins, S., ... Crosby, T. (2017). NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74, 38-46. DOI: 10.1016/j.ejca.2016.11.031
Crabb, S. J., Birtle, A. J., Martin, K., Downs, N., Ratcliffe, I., Maishman, T., ... Jones, R. J. (2017). ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer. Investigational New Drugs, 1-9. DOI: 10.1007/s10637-017-0433-4
Abu Hilal, M., Aldrighetti, L., Dagher, I., Edwin, B., Troisi, R. I., Alikhanov, R., ... Cherqui, D. (2017). The Southampton Consensus Guidelines for laparoscopic liver surgery: from indication to implementation. Annals of Surgery, 268(1), 11-18. DOI: 10.1097/SLA.0000000000002524
Williams, C. L., Weller, S., Roberts, L., Reading, I., Cook, A., Little, L., ... Clarke, N. M. P. (2017). Timing of surgical Intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip ‘Op). Health Technology Assessment. DOI: 10.3310/hta21630
Trill, J., Simpson, C., Webley, F., Radford, M., Stanton, L., Maishman, T., ... Moore, M. (2017). Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial. Trials, 18(421), 1-9. DOI: 10.1186/s13063-017-2145-7
Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., La Rosée, P., ... International Extranodal Lymphoma Study Group (IELSG) (2017). Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. The Lancet Haematology, 4(11), e510-e523. DOI: 10.1016/S2352-3026(17)30174-6
Little, P., Stuart, B., Andreou, P., McDermott, L., Joseph, J., Mullee, M., ... Yardley, L. (2016). A primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor). BMJ Open, 6(e009769), 1-9. DOI: 10.1136/bmjopen-2015-009769
Qureshi, N. R., Rintoul, R. C., Miles, K. A., George, S., Harris, S., Madden, J., ... Gilbert, F. J. (2016). Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study. BMJ Open Respiratory Research, 3(1), [e000156]. DOI: 10.1136/bmjresp-2016-000156
Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Ponzoni, M., Deckert, M., Politi, L. S., ... International Extranodal Lymphoma Study Group (IELSG) (2016). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. The Lancet Haematology, 3(5), e217-27. DOI: 10.1016/S2352-3026(16)00036-3
Qureshi, N. R., Shah, A., Eaton, R. J., Miles, K., Gilbert, F. J., & Sputnik Investigators (2016). Dynamic contrast enhanced CT in nodule characterization: How we review and report. Cancer imaging : the official publication of the International Cancer Imaging Society, 16(1), 16. DOI: 10.1186/s40644-016-0074-4
Kirkpatrick, E., Pearse, J., James, P., & Basu, A. (2016). Effect of parent-delivered action observation therapy on upper limb function in unilateral cerebral palsy: a randomized controlled trial. Developmental Medicine & Child Neurology, 1-8. DOI: 10.1111/dmcn.13109
Little, P., Stuart, B., Mullee, M., Thomas, T., Johnson, S., Leydon, G., ... Moore, M. (2016). Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled trial. Canadian Medical Association Journal, 118(13), 940-949. DOI: 10.1503/cmaj.160362
Eccles, D. M., Li, N., Handwerker, R., Maishman, T., Copson, E. R., Durcan, L. T., ... Campbell, I. (2016). Genetic testing in a cohort of young patients with HER2 amplified breast cancer. Annals of Oncology, 27(3), 467-73. DOI: 10.1093/annonc/mdv592
Maishman, T., Cutress, R., Hernandez, A., Gerty, S., Copson, E., Durcan, L., & Eccles, D. (2016). Local recurrence and breast oncological surgery in young women with breast cancer: the POSH observational cohort study. Annals of Surgery, 1-8. DOI: 10.1097/SLA.0000000000001930
Cathomas, R., Crabb, S. J., Mark, M., Winterhalder, R., Rothermundt, C., Elliott, T., ... Gillessen, S. (2016). Orteronel switch maintenance therapy in metastatic castration resistant prostate cancer after first-line docetaxel: a multicenter, randomized, double-blind, placebo-controlled trial (SAKK 08/11). The Prostate, 76(16), 1519-1527. DOI: 10.1002/pros.23236
Arriola, E., Wheater, M., Galea, I., Cross, N., Maishman, T., Hamid, D., ... Ottensmeier, C. (2016). Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11(9), 1511-1521. DOI: 10.1016/j.jtho.2016.05.028
Pugh, S. A., Bowers, M., Ball, A., Falk, S., Finch-Jones, M., Valle, J. W., ... Primrose, J. N. (2016). Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. British Journal of Cancer, 115, 420-424. DOI: 10.1038/bjc.2016.208
Cipriani, F., Rawashdeh, M., Stanton, L., Armstrong, T., Takhar, A., Pearce, N. W., ... Abu Hilal, M. (2016). Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases. British Journal of Surgery, 103(11), 1504-12. DOI: 10.1002/bjs.10211
Macbeth, F., Noble, S., Evans, J., Ahmed, S., Cohen, D., Hood, K., ... Griffiths, G. (2016). Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC Trial. Journal of Clinical Oncology, 34(5), 488-94. DOI: 10.1200/JCO.2015.64.0268
Illidge, T., McKenzie, H., Mayes, S., Bates, A., Davies, A., Pettengell, R., ... Johnson, P. (2016). Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study. British Journal of Haematology, 173(2), 274-282. DOI: 10.1111/bjh.13954
Pugh, S. A., Shinkins, B., Fuller, A., Mellor, J., Mant, D., & Primrose, J. N. (2016). Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS randomized controlled trial. Annals of Surgery, 263, 1143-7. DOI: 10.1097/SLA.0000000000001351
Schünemann, H. J., Ventresca, M., Crowther, M., Briel, M., Zhou, Q., Garcia, D., ... IPDMA heparin use in cancer patients research group (2016). Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open, 6(4), 1-11. [e010569]. DOI: 10.1136/bmjopen-2015-010569
Harrop, E., Kelly, J., Griffiths, G., Casbard, A., Nelson, A., & Published on behalf of the BOLERO Trial Management Group (TMG) (2016). Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials, 17(35). DOI: 10.1186/s13063-016-1173-z
Maishman, T., Copson, E., Stanton, L., Gerty, S., Dicks, E., Durcan, L., ... Eccles, D. (2015). An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis. British Journal of Cancer, 112(6), 983-991. DOI: 10.1038/bjc.2015.57
Lei, J., Rudolph, A., Moysich, K. B., Rafiq, S., Behrens, S., Goode, E. L., ... KConFab Investigators (2015). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Research, 17(18). DOI: 10.1186/s13058-015-0522-2
Primrose, J. N., Cunningham, D., Garden, O. J., Maughan, T. S., Pugh, S. A., Stanton, L., ... Bridgewater, J. A. (2015). Cetuximab is contraindicated in the perioperative treatment of colorectal liver metastases. Journal of Clinical Oncology, 33(21), 2405-2406. DOI: 10.1200/JCO.2014.60.1344
Eccles, B. K., Copson, E. R., Cutress, R., Maishman, T., Altman, D. G., Simmonds, P., ... Eccles, D. M. (2015). Family history and outcome of young patients with breast cancer in the UK (POSH study). British Journal of Surgery, 102(8), 924-935. DOI: 10.1002/bjs.9816
Hurt, C. N., Mukherjee, S., Bridgewater, J., Falk, S., Crosby, T., McDonald, A., ... Johnson, C. (2015). Health-related quality of Life in SCALOP, a randomized phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics, 93(4), 810-818. DOI: 10.1016/j.ijrobp.2015.08.026
Mukherjee, S., Hurt, C. N., Gwynne, S., Bateman, A., Gollins, S., Radhakrishna, G., ... Crosby, T. (2015). NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC cancer, 15(48). DOI: 10.1186/s12885-015-1062-y
Copson, E. R., Cutress, R. I., Maishman, T., Eccles, B. K., Gerty, S., Stanton, L., ... Jones, L. (2015). Obesity and the outcome of young breast cancer patients in the UK: the POSH study. Annals of Oncology, 26(1), 101-112. DOI: 10.1093/annonc/mdu509
Rees, J., Hurt, C. N., Gollins, S., Mukherjee, S., Maughan, T., Falk, S. J., ... Crosby, T. (2015). Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer, 113(4), 603-610. DOI: 10.1038/bjc.2015.258
Thursz, M. R., Richardson, P., Allison, M., Austin, A., Bowers, M., Day, C. P., ... Forrest, E. H. (2015). Prednisolone or pentoxifylline for alcoholic hepatitis. New England Journal of Medicine, 372(17), 1619-1628. DOI: 10.1056/NEJMoa1412278
Geldart, T., Chester, J., Casbard, A., Crabb, S., Elliott, T., Protheroe, A., ... Griffiths, G. (2015). SUCCINCT: An open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with Sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology, 1-4. DOI: 10.1016/j.eururo.2014.11.003
Thursz, M., Forrest, E., Roderick, P., Day, C., Austin, A., O'Grady, J., ... Ternent, L. (2015). The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. Health Technology Assessment, 19(102), 1-104. DOI: 10.3310/hta191020
Eccles, B. K., Copson, E., Maishman, T., Abraham, J. E., & Eccles, D. M. (2015). Understanding of BRCA VUS genetic results by breast cancer specialists. BMC cancer, 15, 936. DOI: 10.1186/s12885-015-1934-1
Ceriani, L., Martelli, M., Zinzani, P. L., Ferreri, A. J. M., Botto, B., Stelitano, C., ... Zucca, E. (2015). Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood, 126(8), 950-6. DOI: 10.1182/blood-2014-12-616474
Martelli, M., Ceriani, L., Zucca, E., Zinzani, P. L., Ferreri, A. J. M., Vitolo, U., ... Johnson, P. W. M. (2014). [¹⁸F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. Journal of Clinical Oncology, 32(17), 1769-75. DOI: 10.1200/JCO.2013.51.7524
Li, J., Lindström, L. S., Foo, J. N., Rafiq, S., Schmidt, M. K., Pharoah, P. D. P., ... Czene, K. (2014). 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nature Communications, 5, 4051-[9pp]. DOI: 10.1038/ncomms5051
Smith, J. D., Baillie, J., Baglin, T., Griffiths, G. O., Casbard, A., Cohen, D., ... Noble, S. I. (2014). A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. Trials, 15(1), [122]. DOI: 10.1186/1745-6215-15-122
Tristram, A., Hurt, C. N., Madden, T., Powell, N., Man, S., Hibbitts, S., ... Griffiths, G. (2014). Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology, 15(12), 1361-1368. DOI: 10.1016/S1470-2045(14)70456-5
Primrose, J. N., Perera, R., Gray, A., Rose, P., Fuller, A., Corkhill, A., ... Mant, D. (2014). Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. Journal of the American Medical Association, 311(3), 263-270. DOI: 10.1001/jama.2013.285718
Turner, S., Davidson, P., Stanton, L., & Cawdeary, V. (2014). Features of successful bids for funding of applied health research: a cohort study. Health Research Policy and Systems, 12, [54]. DOI: 10.1186/1478-4505-12-54
Purrington, K. S., Slager, S., Eccles, D., Yannoukakos, D., Fasching, P. A., Miron, P., ... Couch, F. J. (2014). Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis, 35(5), 1012-1019. DOI: 10.1093/carcin/bgt404
Barrett-Lee, P., Casbard, A., Abraham, J., Hood, K., Coleman, R., Simmonds, P., ... Murray, N. (2014). Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. The Lancet Oncology, 15(1), 114-122. DOI: 10.1016/S1470-2045(13)70539-4
Adamson, D., Blazeby, J., Nelson, A., Hurt, C., Nixon, L., Fitzgibbon, J., ... Byrne, A. (2014). Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial. Trials, 15, [402]. DOI: 10.1186/1745-6215-15-402
McCann, D. C., Thompson, M., Daley, D., Barton, J., Laver-Bradbury, C., Hutchings, J., ... Sonuga-Barke, E. (2014). Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD. Trials, 15(1), 142. DOI: 10.1186/1745-6215-15-142
Primrose, J., Falk, S., Finch-Jones, M., Valle, J., O'Reilly, D., Siriwardena, A., ... Bridgewater, J. (2014). Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. The Lancet Oncology, 15(6), 601-611. DOI: 10.1016/S1470-2045(14)70105-6
Loveman, E., Jones, J., Clegg, A. J., Picot, J., Colquitt, J., Mendes, D., ... Primrose, J. (2014). The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation. Health Technology Assessment, 18(7), 1-283. DOI: 10.3310/hta18070
Hurt, C. N., Roberts, K., Rogers, T. K., Griffiths, G. O., Hood, K., Prout, H., ... Neal, R. D. (2013). A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials, 14(1), [405]. DOI: 10.1186/1745-6215-14-405
Byrne, A., Sampson, C., Baillie, J., Harrison, K., Hope-Gill, B., Hubbard, R., ... Nelson, A. (2013). A mixed-methods study of the Care Needs of individuals with idiopathic Pulmonary fibrosis and their carers--CaNoPy: a study protocol. BMJ Open, 3(8), [e003537]. DOI: 10.1136/bmjopen-2013-003537
Zucca, E., Conconi, A., Laszlo, D., López-Guillermo, A., Bouabdallah, R., Coiffier, B., ... Thieblemont, C. (2013). Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study. Journal of Clinical Oncology. DOI: 10.1200/JCO.2011.40.6272
Crosby, T., Hurt, C. N., Falk, S., Gollins, S., Mukherjee, S., Staffurth, J., ... Griffiths, G. (2013). Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology, 14(7), 627-637. DOI: 10.1016/S1470-2045(13)70136-0
Blatch-Jones, A., Raftery, J., Stanton, L., & Cook, A. (2013). Do NIHR health technology assessment randomised clinical trials perform as well as expected? Trials, 14(Suppl 1), P92. DOI: 10.1186/1745-6215-14-S1-P92
Copson, E., Maishman, T., Gerty, S., Eccles, B., Stanton, L., Cutress, R. I., ... Eccles, D. (2013). Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. British Journal of Cancer, 110(1), 230-41. DOI: 10.1038/bjc.2013.650
Mukherjee, S., Hurt, C. N., Bridgewater, J., Falk, S., Cummins, S., Wasan, H., ... Maughan, T. (2013). Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology, 14(4), 317-326. DOI: 10.1016/S1470-2045(13)70021-4
Rafiq, S., Tapper, W., Collins, A., Khan, S., Politopoulos, I., Gerty, S., ... Eccles, D. (2013). Identification of inherited genetic variations influencing prognosis in early-onset breast cancer. Cancer Research, 73(6), 1883-1891. DOI: 10.1158/0008-5472.CAN-12-3377
Maddocks, M., Halliday, V., Chauhan, A., Taylor, V., Nelson, A., Sampson, C., ... Wilcock, A. (2013). Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: a randomized phase II study. PLoS ONE, 8(12), e86059. DOI: 10.1371/journal.pone.0086059
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., ... EORTC Gastro-Intestinal Tract Cancer Group (2013). Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. The Lancet Oncology, 14(12), 1208-1215. DOI: 10.1016/S1470-2045(13)70447-9
Copson, E., Eccles, B., Maishman, T., Gerty, S., Stanton, L., Cutress, R. I., ... Eccles, D. (2013). Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study. JNCI Journal of the National Cancer Institute, 105(13), 978-988. DOI: 10.1093/jnci/djt134
Nelson, A., Fenlon, D., Morris, J., Sampson, C., Harrop, E., Murray, N., ... Barrett-Lee, P. (2013). QUALZICE: a QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates. Trials, 14, [325]. DOI: 10.1186/1745-6215-14-325
Eccles, B. K., Cross, W., Rosario, D. J., Doble, A., Parker, C., Logue, J., ... Bottomley, D. (2013). SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer. BJU International, 112(3), 330-7. DOI: 10.1111/bju.12127
Forrest, E., Mellor, J. M., Stanton, L., Bowers, M., Ryder, P., Austin, A., ... Thursz, M. (2013). Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials, 14, 262. DOI: 10.1186/1745-6215-14-262
Bruton, A., Kirby, S., Arden-Close, E., Taylor, L., Webley, F., George, S., ... Thomas, M. (2013). The BREATHE study: Breathing REtraining for Asthma - Trial of Home Exercises. A protocol summary of a randomised controlled trial. Primary Care Respiratory Journal, 22(2), PS1-PS7. DOI: 10.4104/pcrj.2013.00047
Griffiths, G., & Sweeney, L. (2012). Clinical trials in oncology. Medicine, 40(1), 20-23. DOI: 10.1016/j.mpmed.2011.09.014
Djulbegovic, B., Kumar, A., Glasziou, P. P., Perera, R., Reljic, T., Dent, L., ... Chalmers, I. (2012). New treatments compared to established treatments in randomized trials. Cochrane Database of Systematic Reviews, 10, 1-50. DOI: 10.1002/14651858.MR000024.pub3
Shaw, E. C., Hanby, A. M., Wheeler, K., Shaaban, A. M., Poller, D., Barton, S., ... Eccles, D. M. (2012). Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study. Journal of Clinical Pathology, 65(5), 403-408. DOI: 10.1136/jclinpath-2011-200369
van Dam, R. M., Wong-Lun-Hing, E. M., van Breukelen, G. J. P., Stoot, J. H. M. B., van der Vorst, J. R., Bemelmans, M. H. A., ... Primrose, J. N. (2012). Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials, 13(54). DOI: 10.1186/1745-6215-13-54
Raftery, J., Fairbank, E., Douet, L., Dent, L., Price, A., Milne, R., & Walley, T. (2012). Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials. Trials, 13(1), 140. DOI: 10.1186/1745-6215-13-140
Gwynne, S., Spezi, E., Wills, L., Nixon, L., Hurt, C., Joseph, G., ... Staffurth, J. (2012). Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. International Journal of Radiation: Oncology, Biology, Physics, 84(4), 1037-1042. DOI: 10.1016/j.ijrobp.2012.01.094
Dent, L., Taylor, R., Jolly, K., & Raftery, J. (2011). "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation. Trials, 12, 83. DOI: 10.1186/1745-6215-12-83
Haiman, C. A., Chen, G. K., Vachon, C. M., Canzian, F., Dunning, A., Millikan, R. C., ... Couch, F. J. (2011). A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer. Nature Genetics, 43(12), 1210-1214. DOI: 10.1038/ng.985
Yang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., ... Garcia-Closas, M. (2011). Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium Studies. JNCI Journal of the National Cancer Institute, 103(3), 250-263. DOI: 10.1093/jnci/djq526
Stevens, K. N., Vachon, C. M., Lee, A. M., Slager, S., Lesnick, T., Olswold, C., ... Couch, F. J. (2011). Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Research, 71(19), 6240-6249. DOI: 10.1158/0008-5472.CAN-11-1266
Eccles, D. (2011). Development of genetic testing for breast, ovarian and colorectal cancer predisposition: a step closer to targeted cancer prevention. Current Drug Targets, 12(13), 1974-1982. DOI: 10.2174/138945011798184209
Griffiths, G., Hall, R., Sylvester, R., Raghavan, D., Parmar, M. K. B., & International Collaboration of Trialists (2011). International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. Journal of Clinical Oncology, 29(16), 2171-2177. DOI: 10.1200/JCO.2010.32.3139
Hurt, C. N., Nixon, L. S., Griffiths, G. O., Al-Mokhtar, R., Gollins, S., Staffurth, J. N., ... Crosby, T. D. (2011). SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC cancer, 11, [466]. DOI: 10.1186/1471-2407-11-466
Dent, L., & Raftery, J. (2011). Treatment success in pragmatic randomised controlled trials: a review of trials funded by the UK Health Technology Assessment programme. Trials, 12, 109. DOI: 10.1186/1745-6215-12-109
Moyle, P. L., Katako, M., Wheeler, K., Gerty, S., Morrish, O., Wallis, M. G., ... Warren, R. (2011). Validating “Image box”-a new approach to multicentre radiology reviews using a web-based image review system: study protocol. Journal of Biomedical Graphics and Computing, 1(1), 24-32. DOI: 10.5430/jbgc.v1n1p24
Antoniou, A. C., Wang, X., Fredericksen, Z. S., McGuffog, L., Tarrell, R., Sinilnikova, O. M., ... Couch, F. J. (2010). A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population. Nature Genetics, 42(10), 885-892. DOI: 10.1038/ng.669
Wilson, J. R. F., Bateman, A. C., Hanson, H., An, Q., Evans, G., Rahman, N., ... Eccles, D. M. (2010). A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. Journal of Medical Genetics, 47(11), 771-774. DOI: 10.1136/jmg.2010.078113
Stephens, R. J., Thompson, L. C., Quirke, P., Steele, R., Grieve, R., Couture, J., ... Sebag-Montefiore, D. (2010). Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. Journal of Clinical Oncology, 28(27), 4233-9. DOI: 10.1200/JCO.2009.26.5264
Turnbull, C., Hines, S., Renwick, A., Hughes, D., Pernet, D., Elliott, A., ... Rahman, N. (2010). Mutation and association analysis of GEN1 in breast cancer susceptibility. Breast Cancer Research and Treatment, 124(1), 283-288. DOI: 10.1007/s10549-010-0949-1
Eccles, D., & Tapper, W. (2010). The influence of common polymorphisms on breast cancer. Cancer Research, 155, 15-32. DOI: 10.1007/978-1-4419-6033-7_2
Highley, M. S., Griffiths, G. O., Uscinska, B. M., Huddart, R. A., Barber, J. B. P., Parmar, M. K. B., ... NCRI Bladder Cancer Clinical Studies Group (2009). A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract. Clinical Oncology, 21(5), 394-400. DOI: 10.1016/j.clon.2009.01.011
Griffiths, G. O., Burns, S., Noble, S. I., Macbeth, F. R., Cohen, D., & Maughan, T. S. (2009). FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer. BMC cancer, 9, [355]. DOI: 10.1186/1471-2407-9-355
Ahmed, S., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., Morrison, J., ... SEARCH (2009). Newly discovered breast cancer susceptibility loci in 3p24 and 17q23.2. Nature Genetics, 41(5), 585-590. DOI: 10.1038/ng.354
Sebag-Montefiore, D., Stephens, R. J., Steele, R., Monson, J., Grieve, R., Khanna, S., ... Parmar, M. (2009). Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 373(9666), 811-820. DOI: 10.1016/S0140-6736(09)60484-0
Adams, R., Meade, A., Wasan, H., Griffiths, G., & Maughan, T. (2008). Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial. Expert Review of Anticancer Therapy, 8(8), 1237-45. DOI: 10.1586/14737140.8.8.1237
Griffiths, G. (2008). Clinical trials in oncology. Medicine, 36(1), 41-44. DOI: 10.1016/j.mpmed.2007.10.005
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., ... Gruenberger, T. (2008). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet, 371(9617), 1007-1016. DOI: 10.1016/S0140-6736(08)60455-9
Tapper, W., Hammond, V., Gerty, S., Ennis, S., Simmonds, P., Collins, A., ... Posh Steering Group (2008). The influence of genetic variation in thirty selected genes on the clinical characteristics of early onset breast cancer. Breast Cancer Research, 10(6), R108. DOI: 10.1186/bcr2213
Harland, S. J., Kynaston, H., Grigor, K., Wallace, D. M., Beacock, C., Kockelbergh, R., ... National Cancer Research Institute Bladder Clinical Studies Group (2007). A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. The Journal of Urology, 178(3), 807-813. DOI: 10.1016/j.juro.2007.05.024
Seymour, M. T., Maughan, T. S., Ledermann, J. A., Topham, C., James, R., Gwyther, S. J., ... FOCUS Trial Investigators (2007). Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet, 370(9582), 143-52. DOI: 10.1016/S0140-6736(07)61087-3
Eccles, D., Gerty, S., Simmonds, P., Hammond, V., Ennis, S., & Altman, D. G. (2007). Prospective study of outcomes in Sporadic versus hereditary breast cancer (POSH): study protocol. BMC cancer, 7, [6pp]. DOI: 10.1186/1471-2407-7-160
Masters, J. R. W., Vani, U. D., Grigor, K. M., Griffiths, G. O., Crook, A., Parmar, M. K. B., ... MRC Superficial Bladder Cancer Group Mitomycin-C Trial Collaborators (2003). Can p53 staining be used to identify patients with aggressive superficial bladder cancer? The Journal of Pathology, 200(1), 74-81. DOI: 10.1002/path.1293
Parmar, M. K. B., Griffiths, G. O., Spiegelhalter, D. J., Souhami, R. L., Altman, D. G., van der Scheuren, E., & CHART steering committee (2001). Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet, 358(9279), 375-81. DOI: 10.1016/S0140-6736(01)05558-1
Duchesne, G. M., Bolger, J. J., Griffiths, G. O., Trevor Roberts, J., Graham, J. D., Hoskin, P. J., ... Parmar, M. K. (2000). A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. International Journal of Radiation: Oncology, Biology, Physics, 47(2), 379-88.
Saunders, M., Dische, S., Barrett, A., Harvey, A., Griffiths, G., & Palmar, M. (1999). Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiotherapy and Oncology, 52(2), 137-48. DOI: 10.1016/S0167-8140(99)00087-0
Griffiths, G. (1999). Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet, 353(9146), 14-7. DOI: 10.1016/S0140-6736(98)03544-2
Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-Urinary Group, Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, & Club Urologico Espanol de Tratamiento Oncologico (CUETO) group (1999). Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet, 354(9178), 533-540. DOI: 10.1016/S0140-6736(99)02292-8
Robertson, G., Parmar, M., Foy, C., Griffiths, G., Saunders, M., & Dische, S. (1999). Overall treatment time and the conventional arm of the CHART trial in the radiotherapy of head and neck cancer. Radiotherapy and Oncology, 50(1), 25-28. DOI: 10.1016/S0167-8140(98)00116-9
CHART Steering Group (1999). Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy. British Journal of Cancer, 81(7), 1196-1205. DOI: 10.1038/sj.bjc.6690829
MacGregor, A. J., Griffiths, G. O., Baker, J., & Spector, T. D. (1997). Determinants of pressure pain threshold in adult twins: evidence that shared environmental influences predominate. Pain, 73(2), 253-7. DOI: 10.1016/S0304-3959(97)00101-2
Garnero, P., Arden, N. K., Griffiths, G., Delmas, P. D., & Spector, T. D. (1996). Genetic influence on bone turnover in postmenopausal twins. Journal of Clinical Endocrinology & Metabolism, 81(1), 140-146. DOI: 10.1210/jcem.81.1.8550741
Djukanović, R., Finnerty, J. P., Lee, C., Wilson, S. J., Madden, J., & Holgate, S. T. (1995). The effects of theophylline on mucosal inflammation in asthmatic airways: biopsy results. European Respiratory Journal, 8(5), 831-833. DOI: 10.1183/09031936.95.08050831

Conferences

Schunemann, H., Ventresca, M., Crowther, M., Di Nisio, M., Briel, M., Zhou, Q., ... Zulian, G. (2017). An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients. Abstract from 59th ASH Annual Meeting and Exposition, Atlanta, United States.
Davies, A. J., Barrans, S., Maishman, T., Cummin, T. E., Bentley, M., Mamot, C., ... Johnson, P. W. (2017). Differential efficacy of bortezomib in subtypes of diffuse large B‐cell lymphoma (dlbl): a prospective randomised study stratified by transcriptome profiling: remodl‐B. Hematological Oncology, 35(S2), 130-131. DOI: 10.1002/hon.2437_120
Cummin, T. E., Araf, S., Du, M., Barrans, S., Bentley, M. A., Clipson, A., ... Johnson, P. W. (2017). Prognostic significance and correlation to gene expression profile of EZH2 mutations in diffuse large B‐cell lymphoma (DLBL) in 2 large prospective studies. Hematological Oncology, 35(S2), 158-159. DOI: 10.1002/hon.2438_13
Van Es, N., Ventresca, M., Zhou, Q., Noble, S., Crowther, M., Di Nisio, M., ... Schunemann, H. (2017). The Khorana Score for the prediction of venous thromboembolism in patients with solid cancer: An individual patient data meta-analysis. Abstract from 59th ASH Annual Meeting and Exposition, Atlanta, United States.

Letters/Editorials

Cook, A. (Accepted/In press). Commentary on Curtis et al. Clinical Trials.
Djebbari, F., Browning, J. A., Stanton, L., Booth, S., Hildyard, C., Willan, J., ... Eyre, T. A. (2019). Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma. British Journal of Haematology. DOI: 10.1111/bjh.16071
Papadakis, E. S., Reeves, T., Robson, N. H., Maishman, T., Packham, G., & Cutress, R. I. (2018). Reply to ‘Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''. British Journal of Cancer, 118(1154), 1. DOI: 10.1038/s41416-018-0032-y

Reports

Thomas, M., Bruton, A., Little, P., Holgate, S., Lee, A., Yardley, L., ... Taylor, L. (2017). A randomised controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist either by instructional DVD or in face-to-face sessions in the management of asthma in adults. (Health Technology Assessment; Vol. 21, No. 53). NHS England. DOI: 10.3310/hta21530
Raftery, J., Young, A., Stanton, L., Milne, R., Cook, A., Turner, D., & Davidson, P. (2015). Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme. (Health Technology Assessment; No. 19). Southampton, GB: NIHR Journals Library. DOI: 10.3310/hta19110